PCSK9 peptide vaccine conjugated to a Qbeta carrier and methods of using the same
US10279019B2 · kind B2 · utility
2Cited by
19References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 11, 2015 |
| Grant date | May 7, 2019 |
| Priority date | — |
| Expiry date | Feb 11, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2795/18134
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A vaccine construct comprising an antigenic PCSK9 peptide and an immunogenic carrier, and methods of using the same that are effective to lower blood cholesterol levels in a mammal and treat dyslipidemias and related disease states in a mammal without the frequency of administration required by passive immunity strategies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.